Skip to main content

Assessment of severity of bronchial asthma by studying new markers: transforming growth factor-β1 and chitinase-3-like-1

Abstract

Aim

The aim of this work was to look for non-invasive biomarkers that may enable us to assess asthma severity, as a surrogate for the invasive bronchial mucosa biopsy, by studying TGF-β1 and YKL-40.

Objectives

TGF-β1 is used as biomarkers in the pathogenesis, prediction and follow up of asthma severity. YKL-40 has a role in airway inflammation; this relation suggests that YKL-40 and TGF-β1 can be used as biomarkers in the pathogenesis, prediction and follow-up of asthma severity.

Background

Defective extracellular matrix (ECM) turnover characterizes airway remodeling. Transforming Growth Factor Beta-1 (TGF-β1) stimulate airway remodeling through activation of gene transcription via binding to specific subfamilies of cell transmembrane receptors.

Methods

The work was done on a 60 subject aged between 20–40 years with equal sex. Classified into three groups; 20 patients with mild asthma, 20 patients with severe asthma and 20 normal subjects were taken as controls. For all subjects chest X-ray, pulmonary functions tests, allergy skin prick test, eosinophilic count, total IgE, YKL-40 and TGF-β1 in serum were performed.

Results

The results showed that serum TGF-β1 and serum YKL-40 between the three groups were highly significantly different (P<0.01) between the three groups in asthmatic patients compared with control group.

Conclusions

These variations were correlated positively with the severity of the disease indicating that their increased serum levels may be a biological characteristic of the disease exacerbation with a sentinel role in asthma.

References

  1. Yang YC, Zhang N, van Crombruggen K, Hu GH, Hong SL, Bachert C. Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy 2012; 67:1193–1202.

    CAS  Article  Google Scholar 

  2. Mirzamani MS, Nourani MR, Fooladi AAI, Zare S, Ebrahimi M,Yazdani S, et al. Increased expression of TGF-B1 and receptors in primary human airway fibroblast from chemical inhalation patients. Iran J Allergy Asthma Immunol 2013; 12:144–152.

    CAS  PubMed  Google Scholar 

  3. Satwani H, Rehman A, Ashraf S, Hassan A. Is serum total IgE levels a good predictor of allergies in children? J Pak Med Assoc 2009; 59:698–702.

    PubMed  Google Scholar 

  4. Saba M, Sharif MR, Akbri H, Nikoueinejad H, Jolfaii MR. YKL-40 in asthma and its correlation with different clinical parameters. Iran J Allergy Asthma Immunol 2014; 13:271–277.

    PubMed  Google Scholar 

  5. Possa SS, Leick EA, Prado CM, Martins MA, Tibério IF. Eosinophilic inflammation in allergic asthma. Front Pharmacol 2013; 4:46.

    CAS  Article  Google Scholar 

  6. Ito R, Gon Y, Nunomura S, Atsuta R, Harada N, Hattori T, et al. Development of assay for determining free IgE levels in serum from patients treated with omalizumab. Allergol Int 2014; 63(Suppl 1): 37–47.

  7. Wang X, Xing GH. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome. Scand J Clin Lab Invest 2014; 74:74–78.

    CAS  Article  Google Scholar 

  8. Benson DM, Caligiuri MA. Cancer immunology at the crossroads: killer immunoglobulin-like receptors and tumor immunity. Cancer Immunol Res 2014, 2:99–104.

  9. Hassan NAE, Mohamed-Hussein AAR, Mohammed EF, Mohamed OAE, Mohamed HO, et al. Serum transforming growth factor-β1 (TGF-β1) in asthmatics: association between disease control, severity and duration. Biochem Anal Biochem 2015; 4:200.

    Google Scholar 

  10. Manuyakorn W, Kamchaisatian W, Atamasirikul K, Sasisakulporn C, Direkwattanachai C, Benjaponpitak S. Serum TGF-β1 in atopic asthma. Asian Pac J Allergy Immunol 2008 26:185–189.

  11. Joseph J, Benedict S, Badrinath P, Wassef S, Joseph M, Abdulkhalik S, Nicholls MG. Elevation of plasma transforming growth factor beta1 levels in stable non atopic asthma. Ann Allergy Asthma Immunol 2003; 91:472–476.

    CAS  Article  Google Scholar 

  12. Ozyilmaz E, Canbakan S, Capan N, Erturk A, Gulhan M. Correlation of plasma transforming growth factor beta 1 with asthma control test. Allergy Asthma Proc 2009; 30:35–40.

    Article  Google Scholar 

  13. El-Sayed ZA, El-Hakim IZ, El-Kerdani TA, Ghanem HM. Serum transforming growth factor-beta1 in asthmatic children. Egypt J Pediatr Allergy Immunol 2004; 2:46–51.

    Google Scholar 

  14. Chu HW, Trudeau JB, Balzar S, Wenzel SE. Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. J Allergy Clin Immunol 2000; 106:1115–1123.

    CAS  Article  Google Scholar 

  15. Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, Holgate ST, Howarth PH. Transforming growth factor-beta1 in asthma; measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1997; 156:642–647.

    CAS  Article  Google Scholar 

  16. Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, et al. A chitinaselike protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007; 357:2016–2027.

    CAS  Article  Google Scholar 

  17. Kuepper M, Bratke K, Virchow JC. Chitinase-like protein and asthma. N Engl J Med 2008; 358:1073–1075.

    CAS  Article  Google Scholar 

  18. Ober C, Chupp GL. The chitinase and chitinase like proteins: a review of genetic and functional studies in asthma and immunemediated diseases. Curr Opin Allergy Clin Immunol 2009; 9: 401–408.

    CAS  Article  Google Scholar 

  19. Shuhui L, Mok YK, Fred WS. Role of mammalian chitinases in asthma. Int Arch Allergy Immunol 2009; 149:369–377.

    CAS  Article  Google Scholar 

  20. Tang H, Fang Z, Sun Y, Li B, Shi Z, Chen J, et al. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E. Eur Respir J 2010; 35:757–760.

    CAS  Article  Google Scholar 

  21. Sohn MH, Lee JH, Kim KW, Kim SW, Lee SH, Kim KE, et al. Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy. Am J Respir Crit Care Med 2009; 179:449–456.

    CAS  Article  Google Scholar 

  22. Duru S, Yüce G, Ulasli SS, Erdem M, Murat K, Fatma K, Sadik A. The relationship between serum YKL-40 levels and severity of asthma. Iran J Allergy Asthma Immunol 2013; 12:247–2453.

    CAS  PubMed  Google Scholar 

  23. Rotsides DZ, Goldstein IF, Canfield SM, Perzanowski M, Mellins RB, Hoepner L, et al. Asthma, allergy, and IgE levels in NYC head start children. Respir Med 2010; 104:345–355.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Farag Khalil MBBCH, MSc, MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lotfy, A.M., Khalil, F., Zidan, H. et al. Assessment of severity of bronchial asthma by studying new markers: transforming growth factor-β1 and chitinase-3-like-1. Egypt J Intern Med 28, 155–161 (2016). https://doi.org/10.4103/1110-7782.203295

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1110-7782.203295

Keywords

  • asthma severity
  • TGF-β1
  • YKL-40